Acquisition by Ann Varanakis of 83217 shares of Lifestance Health subject to Rule 16b-3
| LFST Stock | USD 7.51 0.01 0.13% |
Slightly above 56% of Lifestance Health's investor base is looking to short. The analysis of overall sentiment of trading Lifestance Health Group stock suggests that many investors are alarmed at this time. Lifestance Health's investing sentiment can be driven by a variety of factors including economic data, Lifestance Health's earnings reports, geopolitical events, and overall market trends.
Lifestance |
Filed transaction by Lifestance Health Group Officer Chief People Officer. Grant, award or other acquisition pursuant to Rule 16b-3
Read at macroaxis.com
Lifestance Health Fundamental Analysis
We analyze Lifestance Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Lifestance Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Lifestance Health based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Shares Outstanding
Shares Outstanding Comparative Analysis
Lifestance Health is currently under evaluation in shares outstanding category among its peers. Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Lifestance Health Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Lifestance Health stock to make a market-neutral strategy. Peer analysis of Lifestance Health could also be used in its relative valuation, which is a method of valuing Lifestance Health by comparing valuation metrics with similar companies.
Peers
Lifestance Health Related Equities
| ACHC | Acadia Healthcare | 4.65 | ||||
| NHC | National HealthCare | 1.73 | ||||
| EHAB | Enhabit | 1.68 | ||||
| PNTG | Pennant | 1.22 | ||||
| INNV | InnovAge Holding | 0.62 | ||||
| ADUS | Addus HomeCare | 0.20 | ||||
| SGRY | Surgery Partners | 0.13 | ||||
| SEM | Select Medical | 0.38 | ||||
| EHC | Encompass Health | 0.52 | ||||
| ENSG | Ensign | 0.72 | ||||
| MODV | ModivCare | 1.49 | ||||
| UHS | Universal Health | 1.92 | ||||
| CCM | Concord Medical | 8.06 |
Additional Tools for Lifestance Stock Analysis
When running Lifestance Health's price analysis, check to measure Lifestance Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lifestance Health is operating at the current time. Most of Lifestance Health's value examination focuses on studying past and present price action to predict the probability of Lifestance Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lifestance Health's price. Additionally, you may evaluate how the addition of Lifestance Health to your portfolios can decrease your overall portfolio volatility.